发明名称 Modulation of systemic memory T cell trafficking
摘要 Methods are provided to specifically modulate the trafficking of systemic memory T cells, particularly CD4+ T cells, without affecting naive T cells or intestinal memory T cells. It is shown that systemic memory T cells, which are characterized as CD45Ra<SUP>-</SUP>, and integrin alpha4beta7<SUP>-</SUP>, express high levels of CCR4. Ligands of CCR4, such as TARC or MDC, act as an adhesion trigger, wherein upon CCR4 binding, these cells undergo integrin-dependent arrest to the appropriate vascular receptor(s). This arrest acts to localize the cells at the target site. The methods of the invention manipulate this triggering, and CCR4 mediated chemotaxis, to affect the localization of T cells in targeted tissues. In an alternative embodiment, the agent is an antagonist that blocks CCR4 biological activity. An advantage of the invention is the selectivity for systemic memory T cells, without affecting native T cells or intestinal memory T cells.
申请公布号 US6881406(B2) 申请公布日期 2005.04.19
申请号 US20010837446 申请日期 2001.04.17
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 BUTCHER EUGENE C.;CAMPBELL JAMES J.;WU LIJUN;ROTTMAN JAMES B.
分类号 A61K45/00;A61K38/00;A61K38/19;A61K39/395;A61P17/02;A61P17/06;A61P19/02;A61P29/00;A61P31/12;A61P37/02;A61P37/08;C07K16/24;C07K16/28;(IPC1-7):A61K39/395 主分类号 A61K45/00
代理机构 代理人
主权项
地址